Verastem Inc is a biopharmaceutical company engaged in discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics.
| Website: | www.verastem.com |
| Main Phone: | +1 781 292-4200 |
| Address: | 117 Kendrick Street |
| Address 2: | Suite 500 |
| State: | MA |
| City / Town: | Needham |
| Country: | USA |
| Postal Code: | 02494 |
| Exchange: | NSD |
| Employees: | 20 |
| NAICS: | Pharmaceutical P |
| Last Price 4.28 | Change $ -0.05 | Change % -1.15 | Tick N/A |
| Bid 4.27 | Bid Size 1,800.00 | Ask 4.29 | Ask Size 3,900.00 |
| Open 4.34 | High 4.34 | Low 4.26 | Prev Close 4.33 |
| Last Trade | Volume 230,772 | 52 Wk Hi 5.71 | 52 Wk Low 1.78 |
| Market Cap 218.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 50,967,973.00 | EPS (TTM) -1.75 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 0 |
| Number of Buys | 0 | 0 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 0 |
| Last 10 Buys | Shares |
|---|---|
| Monica Kleinman | 1,000 |
| John B. Green | 1,000 |
| Robert Forrester | 1,000 |
| John B. Green | 1,000 |
| Daniel Paterson | 1,000 |
| Robert Forrester | 1,000 |
| Christoph H. Westphal | 1,000 |
| Timothy J. Barberich | 1,000 |
| S. Louise Phanstiel | 1,000 |
| Joanna Horobin | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| N/A | 0 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 5 | 5 | 5 | 5 |
| Low Target Price Estimate | 1.5 | 2 | 2 | 2 |
| Mean Target Price Estimate | 2.9 | 3 | 3 | 3.25 |
| Standard Deviation | 1.34 | 1.22 | 1.22 | 1.26 |
| Date of Most Recent Estimate | 08/11/16 | 08/08/16 | 05/11/16 | 08/11/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 32 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-16 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-06-16 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2016-06-14 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2 | 2.17 | 2.29 | 2.29 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
